- €69.99m
- €258.21m
- €78.33m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 73.1 | 25.4 | 33.6 | 106 | 78.3 |
Cost of Revenue | |||||
Gross Profit | 27.3 | 19.2 | 23.1 | 35.5 | 30.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 52.3 | 3.07 | 16.6 | 90.7 | 77.5 |
Operating Profit | 20.7 | 22.3 | 17 | 15 | 0.795 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 16.8 | 17.8 | 13.3 | 15.1 | 7.28 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.5 | 13.4 | 9.89 | 13.2 | 7.49 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 10.1 | 10.8 | 10.2 | 13.2 | 7.31 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.1 | 10.8 | 10.2 | 13.2 | 7.31 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.7 | 1.77 | 1.54 | 2.73 | 1.41 |
Dividends per Share |